Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD) [NA]
A Georgia State University-led clinical trial is evaluating perturbation training to reduce falls in people with Alzheimer disease. The stud…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
A Mayo Clinic-led clinical trial is currently recruiting participants to study neurodegeneration and neuronal fluctuations in Lewy body deme…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: The Locus Coeruleus, Norepinephrine and Cognitive Aging [NA]
This clinical trial in recruitment is studying the relationship between the locus coeruleus, norepinephrine, and cognitive aging in individu…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Quantification of Hsp90 in the Human Brain [NA]
A recruiting clinical study aims to quantify Hsp90 levels in the human brain to explore its role in Parkinson's disease, Alzheimer's disease…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Open-label Extension Study in Participants With Early Alzheimer's Disease [Phase 2]
This document details an open-label extension study (Phase 2) for participants with early Alzheimer's disease, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study
Update on the IDEAS study evaluating amyloid PET imaging for dementia diagnosis; the trial has completed.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Cannabidiol Medication Intervention Trial [Phase 2]
A Phase 2 clinical trial evaluating cannabidiol as an intervention for Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Brain Health & the Microbiome
A George Washington University clinical trial investigating brain health and the microbiome has completed. The study enrolled participants w…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: STIM+: PET Biomarker Education & Disclosure [NA]
STIM+ PET biomarker education and disclosure trial has completed and posted results. Sponsored by the University of Michigan, the study eval…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Senicapoc in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update on Senicapoc for Alzheimer's disease and mild cognitive impairment; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease [NA]
A Johns Hopkins University-sponsored clinical trial investigating cognitive vulnerability to stress in people at risk for Alzheimer's diseas…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Nabilone for Agitation Blinded Intervention Trial [Phase 3]
Phase 3 blinded trial of nabilone for agitation in Alzheimer disease is currently recruiting at Sunnybrook Health Sciences Centre.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: MEMORI Corps: Activity-based Companion Care for Dementia [NA]
The MEMORI Corps trial evaluating activity-based companion care for dementia completed, and results have been posted.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Feasibility of Lecanemab Registry and Clinical Outcome Measures
Feasibility study assessing a lecanemab patient registry and the planned clinical outcome measures for Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Repeat Intracerebroventricular Injections of RB-ADSC in Subjects Previously Treated in RBI Protocol RB-ADSC-02 [Phase 1]
Phase 1 clinical trial update on repeat intracerebroventricular injections of RB-ADSC in Alzheimer's disease patients previously treated in …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial update for ONO-2020 in adults with mild to moderate Alzheimer's disease, noting the study is active but not current…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases [Phase 1, Phase 2]
Clinical trial update describing PET brain imaging studies in multiple sclerosis and Alzheimer's disease, as well as other neurological and …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Epileptic Hippocampus in Alzheimer's Disease [Phase 1, Phase 2]
A clinical trial update describes Phase 1 and Phase 2 investigations into epileptic activity in the hippocampus of Alzheimer's disease, spon…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK [Phase 1]
A Phase 1 trial evaluating NIO752's effect on tau synthesis in Alzheimer's disease, including autosomal dominant familial forms caused by PS…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)
The Monument Test is introduced as a new assessment tool to evaluate the ability to name and identify unique entities in Alzheimer’s disease…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease [Phase 1, Phase 2]
Clinical trial update on allogeneic adipose tissue-derived stem cells for Alzheimer’s disease in Phase 1/Phase 2; status is not yet recruiti…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease
This completed study reports the discovery of novel biomarkers that could enable earlier detection of Alzheimer's disease, potentially befor…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Sweet Night (Musical Diffusion by Caregivers ): Effects of Musical Diffusion by Caregivers on Sleep Onset and Behavioral Regulation in a Protected Living
Clinical trial update for a study on musical diffusion by caregivers to improve sleep onset and behavioral regulation in people with Alzheim…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Self-Care for Dementia Caregivers [NA]
A completed clinical trial evaluating self-care support for dementia caregivers has posted results in January 2026.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Biomarker Exploration in Aging, Cognition and Neurodegeneration [Phase 3]
Phase 3 clinical trial update exploring biomarkers in aging, cognition and neurodegeneration for Alzheimer’s disease and related cognitive c…